Kiniksa Pharmaceuticals International, plc KNSA Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on trailing twelve months.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's free cash flow yield?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported free cash flow yield of 4.5% in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's free cash flow yield changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's free cash flow yield increased by 56.4% year-over-year, from 2.8% to 4.5%.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's free cash flow yield?
- Over 4 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's free cash flow yield has grown at a -21.1% compound annual growth rate (CAGR), from -11.2% to 4.4%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.